Combination of radiological and biochemical methods to assess bone mineral density of mandible in fully edentulous patients after chemotherapy: a 5-year prospective study
暂无分享,去创建一个
L. Chow | W. Loo | Min Wang | M. N. Cheung | L. Jin
[1] U. Albert,et al. The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer. , 2009, European journal of cancer.
[2] J. Twiss,et al. Bone Mineral Density and Bone Turnover in Postmenopausal Women Treated for Breast Cancer , 2008, Cancer nursing.
[3] Kimito Yamada,et al. [Cancer treatment-induced bone loss. Treatment for breast cancer]. , 2008, Clinical calcium.
[4] A. Piattelli,et al. Histologic analysis of human peri-implant bone in type 1 osteoporosis. , 2008, The Journal of oral implantology.
[5] P. Vestergaard,et al. Adverse bone effects during pharmacological breast cancer therapy , 2008, Acta oncologica.
[6] R. Palmer,et al. A comparison of bone mineral density in the spine, hip and jaws of edentulous subjects. , 2007, Clinical oral implants research.
[7] M. Koršić,et al. Assessment Tools in Early Detection of Osteoporosis in Dentistry , 2007, Arhiv za higijenu rada i toksikologiju.
[8] L. Fitzpatrick. Estrogen therapy for postmenopausal osteoporosis. , 2006, Arquivos brasileiros de endocrinologia e metabologia.
[9] C. Blomqvist,et al. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] R. Hajjar,et al. Osteoporosis for the home care physician. Part 1: etiology and current diagnostic strategies. , 2004, Journal of the American Medical Directors Association.
[11] K. Clough,et al. Le traitement chirurgical conservateur du cancer du sein , 2004 .
[12] B. Ramaswamy,et al. Osteopenia and osteoporosis in women with breast cancer. , 2003, Seminars in oncology.
[13] W. Sauerbrei,et al. Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) , 2003, Osteoporosis International.
[14] D. Bourgeois,et al. Trabecular alveolar bone in the human mandible: a dual-energy x-ray absorptiometry study. , 2003, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[15] B. Evans,et al. In Vitro Effects of Chemotherapeutic Agents on Human Osteoblast-like cells , 2002, Calcified Tissue International.
[16] C. Blomqvist,et al. Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment. , 2001, European journal of cancer.
[17] J. Manola,et al. Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] J. Pfeilschifter,et al. Osteoporosis due to cancer treatment: pathogenesis and management. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] B. Drozdzowska,et al. Mandibular bone mineral density measured using dual-energy X-ray absorptiometry: relationship to hip bone mineral density and quantitative ultrasound at calcaneus and hand phalanges. , 2000, The British journal of radiology.
[20] S. Lillicrap,et al. Gamma-ray scattering for mandibular bone density measurement. , 1999, The British journal of radiology.
[21] Y. Zhou,et al. [The comparison of bone densities of mandible and coxofemoral region between senile people with edentulous jaws and those with dentate jaws]. , 1999, Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology.
[22] F. Bassi,et al. Bone density in human dentate and edentulous mandibles using computed tomography. , 1999, Clinical oral implants research.
[23] T. Powles,et al. Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer. , 1998, Journal of the National Cancer Institute.
[24] P. Delmas,et al. Bone loss induced by cancer treatment and its management. , 1998, European journal of cancer.
[25] C. Blomqvist,et al. Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] K Horner,et al. Mandibular bone mineral density as a predictor of skeletal osteoporosis. , 1996, The British journal of radiology.
[27] M. Cobleigh,et al. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] A. Fourquet,et al. [Breast-conserving therapy of breast cancer]. , 2004, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.
[29] G. Wolfinger,et al. Dental implants in the diabetic patient: a retrospective study. , 1999, Implant dentistry.
[30] G. Carlsson,et al. Clinical morbidity and sequelae of treatment with complete dentures. , 1998, The Journal of prosthetic dentistry.
[31] D. Casciato. Manual of Clinical Oncology , 1995 .
[32] R. Love,et al. Manual of Clinical Oncology , 1990, UICC International Union Against Cancer.